RA CAPITAL MANAGEMENT L.P. 13D and 13G filings for Tyra Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-06-06 4:50 pm Purchase | 2025-06-04 | 13D | Tyra Biosciences, Inc. TYRA | RA CAPITAL MANAGEMENT L.P. | 11,899,788 22.400% | 1,214,898 (+11.37%) | Filing |
| 2025-03-31 4:54 pm Purchase | 2025-03-27 | 13D | Tyra Biosciences, Inc. TYRA | RA CAPITAL MANAGEMENT L.P. | 10,684,890 20.100% | 7,750 (+0.07%) | Filing |
| 2024-11-13 6:04 pm Purchase | 2024-11-08 | 13D | Tyra Biosciences, Inc. TYRA | RA CAPITAL MANAGEMENT L.P. | 10,677,140 21.100% | 586,069 (+5.81%) | Filing |
| 2024-10-22 5:11 pm Sale | 2024-10-18 | 13D | Tyra Biosciences, Inc. TYRA | RA CAPITAL MANAGEMENT L.P. | 10,091,071 19.990% | -384,418 (-3.67%) | Filing |
| 2024-02-06 4:40 pm Purchase | 2024-02-06 | 13D | Tyra Biosciences, Inc. TYRA | RA CAPITAL MANAGEMENT L.P. | 10,475,489 19.990% | 3,239,035 (+44.76%) | Filing |
| 2021-09-27 4:30 pm Purchase | 2021-09-17 | 13D | Tyra Biosciences, Inc. TYRA | RA CAPITAL MANAGEMENT L.P. | 7,236,454 17.000% | 7,236,454 (New Position) | Filing |